A parallel, double-blinded, randomized, 6 months, two arms study with lifestyle intervention and exenatide 2 mg once weekly or lifestyle intervention and placebo in adolescents with obesity to explore differences between groups with regard to change in BMI SDS (according to WHO).
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Jan 2017
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms Combat-JUDO
- 14 Jan 2017 This trial has been completed in Sweden (End date:2016-09-13) as per European Clinical Trials Database record.
- 08 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 25 Nov 2015 New trial record